205 related articles for article (PubMed ID: 29620211)
1. MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.
Pan Z; Ding Q; Guo Q; Guo Y; Wu L; Wu L; Tang M; Yu H; Zhou F
Int J Oncol; 2018 Jul; 53(1):59-72. PubMed ID: 29620211
[TBL] [Abstract][Full Text] [Related]
2. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
3. Aberrant high expression level of MORC2 is a common character in multiple cancers.
Ding QS; Zhang L; Wang BC; Zeng Z; Zou XQ; Cao PB; Zhou GM; Tang M; Wu L; Wu LL; Yu HG; Guo Y; Zhou FX
Hum Pathol; 2018 Jun; 76():58-67. PubMed ID: 29555576
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer.
Lin Q; Ling YB; Chen JW; Zhou CR; Chen J; Li X; Huang MS
Int J Oncol; 2018 Jul; 53(1):246-256. PubMed ID: 29658568
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
Wang T; Qin ZY; Wen LZ; Guo Y; Liu Q; Lei ZJ; Pan W; Liu KJ; Wang XW; Lai SJ; Sun WJ; Wei YL; Liu L; Guo L; Chen YQ; Wang J; Xiao HL; Bian XW; Chen DF; Wang B
Cell Death Differ; 2018 Dec; 25(12):2086-2100. PubMed ID: 29555977
[TBL] [Abstract][Full Text] [Related]
6. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.
Wang G; Song Y; Liu T; Wang C; Zhang Q; Liu F; Cai X; Miao Z; Xu H; Xu H; Cao L; Li F
Oncotarget; 2015; 6(12):9877-86. PubMed ID: 25888627
[TBL] [Abstract][Full Text] [Related]
7. MORC2 Enhances Tumor Growth by Promoting Angiogenesis and Tumor-Associated Macrophage Recruitment via Wnt/β-Catenin in Lung Cancer.
Liu M; Sun X; Shi S
Cell Physiol Biochem; 2018; 51(4):1679-1694. PubMed ID: 30504718
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA FOXD2‑AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway.
Huang P; Xue J
Int J Mol Med; 2020 Oct; 46(4):1477-1489. PubMed ID: 32945354
[TBL] [Abstract][Full Text] [Related]
9. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
10. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways.
Du F; Sun L; Chu Y; Li T; Lei C; Wang X; Jiang M; Min Y; Lu Y; Zhao X; Nie Y; Fan D
Cancer Commun (Lond); 2018 Jul; 38(1):45. PubMed ID: 29976242
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.
Zhang H; Tian Y; Shen J; Wang Y; Xu Y; Wang Y; Han Z; Li X
Int J Oncol; 2014 Aug; 45(2):719-31. PubMed ID: 24899407
[TBL] [Abstract][Full Text] [Related]
12. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
13. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma.
Ribback S; Che L; Pilo MG; Cigliano A; Latte G; Pes GM; Porcu A; Pascale RM; Li L; Qiao Y; Dombrowski F; Chen X; Calvisi DF
Cell Cycle; 2018; 17(12):1496-1512. PubMed ID: 29965794
[TBL] [Abstract][Full Text] [Related]
14. MiR-181b promotes chemoresistance in breast cancer by regulating Bim expression.
Zheng Y; Lv X; Wang X; Wang B; Shao X; Huang Y; Shi L; Chen Z; Huang J; Huang P
Oncol Rep; 2016 Feb; 35(2):683-90. PubMed ID: 26572075
[TBL] [Abstract][Full Text] [Related]
15. By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.
Zhang Q; Song Y; Chen W; Wang X; Miao Z; Cao L; Li F; Wang G
Oncotarget; 2015 Jun; 6(18):16461-70. PubMed ID: 26098774
[TBL] [Abstract][Full Text] [Related]
16. MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cells.
Saroha HS; Kumar Guddeti R; Jacob JP; Kumar Pulukuri K; Karyala P; Pakala SB
Med Oncol; 2022 Jun; 39(9):135. PubMed ID: 35727356
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
19. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
20. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
